#STROKE: The CAS-CARE study showed that addition of cilostazol to other antiplatelet agents could contribute to the reduction of in-stent restenosis in the chronic stage of patients who underwent carotid-artery stenting. 💊 #AHAJournals https://t.co/0Nng0e4VSl
🧵/ Late breaking science results from #AHA24 will be posted to this thread at the time of presentation:
BPROAD
SUMMIT
NTLA-2001
VANISH2
OPTION
BRAIN AF
PHARM-HF A&F
AI-ECHO
GLORIOUS
CLEAR SYNERGY
MHYH
ALPACAR
⬇️
(bookmark this post)
When contrast is giving you a headache...😱🤯 Check out our review on #contrast induced encephalopathy🧠under-reported complication of #endovascular procedures⚠️ @mayank_G0 A. Stebner S. Bosshardt @nicolinHAINC et al #INR#neurorad#meded ⏩https://t.co/6NrQfu5sxV
@SposatoL Differences in Stroke Recurrence Risk Between Atrial Fibrillation Detected on ECG and 14-Day Cardiac Monitoring | Stroke https://t.co/Nblycvdgvq
Dual Antiplatelet Therapy (DAPT) vs Alteplase for Minor Nondisabling AIS #ARAMIS
In patients with minor, nondisabling stroke within 4.5h, DAPT was noninferior vs IV alteplase re 90-day excellent outcome (mRS 0-1).
Led by Hui-Sheng Chen et al.
https://t.co/sQPOPXv8ci